These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10707825)

  • 1. Cardiac membrane proteins and phospholipids in L-NAME induced hypertension.
    Ziaciková J; Pechánová O; Bernátová I; Vrbjar N
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():13-5. PubMed ID: 10707825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
    Rauchová H; Pechánová O; Kunes J; Vokurková M; Dobesová Z; Zicha J
    Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional alterations of cardiac (Na,K)-ATPase in L-NAME induced hypertension.
    Vrbjar N; Bernátová I; Pechánová O
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():10-2. PubMed ID: 10707824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I; Pechánová O; Pelouch V; Simko F
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell rheological alterations in hypertension induced by chronic inhibition of nitric oxide synthesis in rats.
    Bor-Küçükatay M; Yalçin O; Gökalp O; Kipmen-Korgun D; Yesilkaya A; Baykal A; Ispir M; Senturk UK; Kaputlu I; Başkurt OK
    Clin Hemorheol Microcirc; 2000; 22(4):267-75. PubMed ID: 11081464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats.
    Hsieh NK; Wang JY; Liu JC; Wang SD; Chen HI
    Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):212-8. PubMed ID: 15053816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bulbus Fritillaria water extract on blood pressure and renal functions in the L-NAME-induced hypertensive rats.
    Kang DG; Sohn EJ; Lee YM; Lee AS; Han JH; Kim TY; Lee HS
    J Ethnopharmacol; 2004 Mar; 91(1):51-6. PubMed ID: 15036467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin protects myocardium from ischemia-reperfusion injury in hypertensive rats: role of myeloperoxidase activity.
    Sahna E; Deniz E; Bay-Karabulut A; Burma O
    Clin Exp Hypertens; 2008 Oct; 30(7):673-81. PubMed ID: 18855270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats.
    Benova M; Herichova I; Stebelova K; Paulis L; Krajcirovicova K; Simko F; Zeman M
    Hypertens Res; 2009 Apr; 32(4):242-7. PubMed ID: 19262491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of nitric oxide in the locomotor activity of hypertensive rats.
    Pechánová O; Jendeková L; Kojsová S; Jagla F
    Behav Brain Res; 2006 Nov; 174(1):160-6. PubMed ID: 16934880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide modulates air embolism-induced lung injury in rats with normotension and hypertension.
    Liu YC; Kao SJ; Chuang IC; Chen HI
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1173-80. PubMed ID: 17880373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
    Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
    Wu D; Cederbaum A
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle and jejunal protein synthesis in normal and ethanol-treated rats: the effect of the nitric oxide synthase inhibitors, L-omega-nitro-L-arginine methyl ester and N(G)-nitro-L-arginine in vivo.
    Rajendram R; Marway JS; Mantle D; Peters TJ; Preedy VR
    Metabolism; 2003 Apr; 52(4):397-401. PubMed ID: 12701048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
    Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
    Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S
    Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
    Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
    Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
    Benter IF; Francis I; Cojocel C; Juggi JS; Yousif MH; Canatan H
    Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.